581 related articles for article (PubMed ID: 12769347)
1. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
Prus E; Fibach E
Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
[TBL] [Abstract][Full Text] [Related]
3. The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors.
Costello R; Mallet F; Chambost H; Sainty D; Arnoulet C; Gastaut JA; Olive D
Leukemia; 1999 Oct; 13(10):1513-8. PubMed ID: 10516751
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid-induced CD38 antigen as a target for immunotoxin-mediated killing of leukemia cells.
Mehta K; Ocanas L; Malavasi F; Marks JW; Rosenblum MG
Mol Cancer Ther; 2004 Mar; 3(3):345-52. PubMed ID: 15026555
[TBL] [Abstract][Full Text] [Related]
5. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells.
Terstappen LW; Safford M; Unterhalt M; Könemann S; Zurlutter K; Piechotka K; Drescher M; Aul C; Büchner T; Hiddemann W
Leukemia; 1992 Oct; 6(10):993-1000. PubMed ID: 1383649
[TBL] [Abstract][Full Text] [Related]
7. The effect of tetraethylenepentamine, a synthetic copper chelating polyamine, on expression of CD34 and CD38 antigens on normal and leukemic hematopoietic cells.
Prus E; Peled T; Fibach E
Leuk Lymphoma; 2004 Mar; 45(3):583-9. PubMed ID: 15160922
[TBL] [Abstract][Full Text] [Related]
8. Rapid induction of CD38 antigen on myeloid leukemia cells by all trans-retinoic acid.
Drach J; Zhao S; Malavasi F; Mehta K
Biochem Biophys Res Commun; 1993 Sep; 195(2):545-50. PubMed ID: 7690555
[TBL] [Abstract][Full Text] [Related]
9. All-trans-retinoic acid up-regulates CD38 but not c-Kit antigens on human marrow CD34+ cells without recruitment into cell cycle.
Herault O; Domenech J; Degenne M; Bremond JL; Sensebe L; Bernard MC; Binet C; Colombat P
Br J Haematol; 1998 Nov; 103(2):343-50. PubMed ID: 9827903
[TBL] [Abstract][Full Text] [Related]
10. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.
Bonnet D; Dick JE
Nat Med; 1997 Jul; 3(7):730-7. PubMed ID: 9212098
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid receptor antagonist inhibits CD38 antigen expression on human hematopoietic cells in vitro.
Prus E; Chandraratna RA; Fibach E
Leuk Lymphoma; 2004 May; 45(5):1025-35. PubMed ID: 15291363
[TBL] [Abstract][Full Text] [Related]
12. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.
Kawagoe H; Humphries RK; Blair A; Sutherland HJ; Hogge DE
Leukemia; 1999 May; 13(5):687-98. PubMed ID: 10374871
[TBL] [Abstract][Full Text] [Related]
13. Requirement of retinoids for the expression of CD38 on human hematopoietic progenitors in vitro.
Muench MO; Bárcena A; Ohkubo T; Harrison MR
Cytotherapy; 1999; 1(6):455-68. PubMed ID: 20426546
[TBL] [Abstract][Full Text] [Related]
14. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells.
Ito S; Barrett AJ; Dutra A; Pak E; Miner S; Keyvanfar K; Hensel NF; Rezvani K; Muranski P; Liu P; Larochelle A; Melenhorst JJ
Stem Cell Res; 2015 Jan; 14(1):95-104. PubMed ID: 25535865
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol 3-kinases are involved in the all-trans retinoic acid-induced upregulation of CD38 antigen on human haematopoietic cells.
Lewandowski D; Linassier C; Iochmann S; Degenne M; Domenech J; Colombat P; Binet C; Hérault O
Br J Haematol; 2002 Aug; 118(2):535-44. PubMed ID: 12139742
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.
Herrmann H; Blatt K; Shi J; Gleixner KV; Cerny-Reiterer S; Müllauer L; Vakoc CR; Sperr WR; Horny HP; Bradner JE; Zuber J; Valent P
Oncotarget; 2012 Dec; 3(12):1588-99. PubMed ID: 23249862
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.
Haase D; Feuring-Buske M; Schäfer C; Schoch C; Troff C; Gahn B; Hiddemann W; Wörmann B
Leukemia; 1997 May; 11(5):674-9. PubMed ID: 9180291
[TBL] [Abstract][Full Text] [Related]
18. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
Al-Mawali A; Gillis D; Lewis I
J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
[TBL] [Abstract][Full Text] [Related]
19. AML bearing the translocation t(11;17)(q23;q21): involvement of MLL and a region close to RARA, with no differentiation response to retinoic acid.
Classen CF; Teigler-Schlegel A; Röttgers S; Reinhardt D; Döhner K; Debatin KM
Ann Hematol; 2005 Nov; 84(12):774-80. PubMed ID: 16044313
[TBL] [Abstract][Full Text] [Related]
20. Induction of CD38/NADase and its monoclonal antibody-induced tyrosine phosphorylation in human leukemia cell lines.
Kontani K; Kukimonto I; Kanda Y; Inoue S; Kishimoto H; Hoshino S; Katada T
Biochem Biophys Res Commun; 1996 May; 222(2):466-71. PubMed ID: 8670228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
